Accepted for Publication: November 1, 2021.
Published: December 23, 2021. doi:10.1001/jamanetworkopen.2021.40906
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Keegan LT et al. JAMA Network Open.
Corresponding Author: Lindsay T. Keegan, PhD, Division of Epidemiology, Internal Medicine, University of Utah, 295 Chipeta Way, Salt Lake City, UT 84108 (lindsay.keegan@utah.edu).
Author Contributions: Drs Keegan and Lessler had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Keegan, Truelove.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: All authors.
Obtained funding: Keegan.
Administrative, technical, or material support: Keegan.
Conflict of Interest Disclosures: Dr Keegan reported receiving grants from the National Institutes of Health (NIH) and receiving research contracts from Pfizer and Becton Dickinson Research outside the submitted work. Dr Lessler reported receiving grants from the NIH and the US Department of Health and Human Services and serving as an expert witness for Cohen Ziffer Frenchman and McKenna on cases related to COVID-19 outside the submitted work. Dr Truelove reported consulting on SARS-CoV-2 transmission, modeling, and projected impacts outside the submitted work. No other disclosures were reported.
Funding/Support: Dr Keegan was supported by grant 5U01CK000585-02 and 5U01CK000555-02 from the Centers for Disease Control and Prevention. Dr Truelove was supported by a National Science Foundation COVID-19 RAPID award. Drs Truelove and Lessler were supported by grants from the US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response to the Johns Hopkins Applied Physics Laboratory.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank the Utah Department of Health for their tireless efforts to collect and share data on SARS-CoV-2 infection, vaccination, and sequencing.
5.Orenstein
WA , Bernier
RH , Dondero
TJ ,
et al. Field evaluation of vaccine efficacy.
Bull World Health Organ. 1985;63(6):1055-1068.
PubMedGoogle Scholar